| 1403 |
1301: Activation, SREBP-1 |
258: Activation, SCD-1 |
Apr 12, 2017 |
Apr 12, 2017 |
None
|
| 294 |
264: Activation, SREBP-1c |
89: Synthesis, De Novo Fatty Acid (FA) |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 295 |
265: Activation, Stellate cells |
68: Accumulation, Collagen |
Nov 29, 2016 |
Dec 5, 2018 |
2 AOPs
|
| 2892 |
265: Activation, Stellate cells |
1501: Increased extracellular matrix deposition |
Apr 13, 2023 |
Jan 30, 2025 |
1 AOP
|
| 3217 |
265: Activation, Stellate cells |
459: Increased, Liver Steatosis |
May 14, 2024 |
May 14, 2024 |
None
|
| 1016 |
978: Activation, Suppression of NFAT activation and hindrance of nuclear localization |
979: Interference, nuclear localization of NFAT |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 1370 |
1283: Activation, TGF-beta pathway |
1277: Reproductive failure |
Feb 15, 2017 |
Feb 15, 2017 |
1 AOP
|
| 2153 |
1283: Activation, TGF-beta pathway |
1457: EMT |
Jul 9, 2020 |
Jul 9, 2020 |
1 AOP
|
| 1832 |
1576: Activation, Tissue resident cells (Kuppfer cells) |
1579: Increase, proinflammatory mediators (TNFalpha) |
Jan 7, 2019 |
Jan 7, 2019 |
1 AOP
|
| 1652 |
1469: TGFbeta pathway activation |
1456: Differentiation of fibroblasts |
Aug 16, 2017 |
Aug 16, 2017 |
1 AOP
|
| 1653 |
1469: TGFbeta pathway activation |
1457: EMT |
Aug 16, 2017 |
Aug 16, 2017 |
1 AOP
|
| 301 |
272: Activation/Proliferation, T-cells |
312: N/A, Allergic contact dermatitis on challenge |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 835 |
272: Activation/Proliferation, T-cells |
827: sensitisation, skin |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 1701 |
272: Activation/Proliferation, T-cells |
313: Increase, Allergic Respiratory Hypersensitivity Response |
Dec 7, 2017 |
Aug 1, 2022 |
1 AOP
|
| 3332 |
272: Activation/Proliferation, T-cells |
2256: Activation of gluten- and TG2-reactive B cells |
Aug 13, 2024 |
Aug 13, 2024 |
None
|
| 3334 |
272: Activation/Proliferation, T-cells |
1931: Disruption of the intestinal barrier |
Aug 13, 2024 |
Aug 13, 2024 |
None
|
| 3337 |
272: Activation/Proliferation, T-cells |
2252: Formation of HLA-DQ2/8-gluten complexes |
Aug 13, 2024 |
Aug 13, 2024 |
None
|
| 2157 |
1793: AP-1 activation |
1795: TGFbeta expression |
Jul 9, 2020 |
Jul 9, 2020 |
1 AOP
|
| 2523 |
1937: ADAM17 induction |
1938: ACE2 increased shedding |
Oct 28, 2021 |
Oct 28, 2021 |
None
|
| 2696 |
2025: Affected folate transporter |
2026: decrease folate |
Jul 19, 2022 |
Jul 19, 2022 |
1 AOP
|
| 31 |
25: Agonism, Androgen receptor |
129: Reduction, Gonadotropins, circulating concentrations |
Nov 29, 2016 |
Mar 20, 2017 |
1 AOP
|
| 32 |
25: Agonism, Androgen receptor |
274: Reduction, Testosterone synthesis by ovarian theca cells |
Nov 29, 2016 |
Mar 20, 2017 |
1 AOP
|
| 1384 |
25: Agonism, Androgen receptor |
3: Reduction, 17beta-estradiol synthesis by ovarian granulosa cells |
Mar 17, 2017 |
Mar 20, 2017 |
1 AOP
|
| 1385 |
25: Agonism, Androgen receptor |
285: Reduction, Vitellogenin synthesis in liver |
Mar 17, 2017 |
Mar 20, 2017 |
1 AOP
|
| 2260 |
25: Agonism, Androgen receptor |
1790: Increased, Differentiation to Testis |
Jan 12, 2021 |
Jan 3, 2023 |
1 AOP
|